TrademarkDir
CLINICAL CANCER RESEARCH
LIVE

Serial Number

85937386

Owner

AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.

Attorney

Mark A. Steiner, Esq.

First Use Date

Jul 1, 1994

Filing Date

May 20, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CLINICAL CANCER RESEARCH Trademark

Serial Number: 85937386 • Registration: 4718260

CLINICAL CANCER RESEARCH is a trademark filed by AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC. on May 20, 2013. The trademark is classified under Class 41 (Education & Entertainment), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC. (44 trademarks)

WEST BUILDING ROOM 301
PHILADELPHIA, PA 19140

Entity Type: 03

Trademark Details

Filing Date

May 20, 2013

Registration Date

April 7, 2015

First Use Anywhere

July 1, 1994

First Use in Commerce

January 15, 1995

Goods & Services

Providing online journals in the field of cancer research and education

[ Journals featuring information in the field of cancer research and education ]

Filing History

NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
Aug 12, 2025 NP89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 12, 2025 RNL1
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Aug 12, 2025 9G8P
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Aug 12, 2025 8PRT
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 12, 2025 APRE
TEAS SECTION 8 & 9 RECEIVED
Mar 28, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 7, 2024 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jul 21, 2021 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jul 21, 2021 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 21, 2021 APRE
TEAS SECTION 8 RECEIVED
Mar 25, 2021 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 7, 2020 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 3, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 3, 2015 REAP
REGISTERED-SUPPLEMENTAL REGISTER
Apr 7, 2015 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 27, 2015 PREV
EXPARTE APPEAL TERMINATED
Feb 20, 2015 EXPT
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Feb 20, 2015 CNTA
EXAMINER'S AMENDMENT ENTERED
Feb 20, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 20, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 20, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 20, 2015 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 20, 2015 ZZZX
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Feb 20, 2015 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2015 CRFA
EX PARTE APPEAL-INSTITUTED
Jan 30, 2015 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 30, 2015 JURT
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 29, 2015 ERFR
EXPARTE APPEAL RECEIVED AT TTAB
Jan 29, 2015 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 29, 2014 GNFN
FINAL REFUSAL E-MAILED
Jul 29, 2014 GNFR
FINAL REFUSAL WRITTEN
Jul 29, 2014 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2014 CRFA
ASSIGNED TO LIE
Jun 27, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 15, 2013 GNRN
NON-FINAL ACTION E-MAILED
Dec 15, 2013 GNRT
NON-FINAL ACTION WRITTEN
Dec 15, 2013 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 11, 2013 GNRN
NON-FINAL ACTION E-MAILED
Sep 11, 2013 GNRT
NON-FINAL ACTION WRITTEN
Sep 11, 2013 CNRT
ASSIGNED TO EXAMINER
Sep 5, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 31, 2013 NWOS
NEW APPLICATION ENTERED
May 23, 2013 NWAP

Related Trademarks

More from this Owner

CANCER RESEARCH

CANCER RESEARCH

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CLINICAL CANCER RESEARCH

CLINICAL CANCER RESEARCH

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CANCER RESEARCH SAVES LIVES

CANCER RESEARCH SAVES LIVES